Today, the Chairman & CEO of Iridex Corp (NASDAQ: IRIX), William M. Moore, bought shares of IRIX for $65.6K.
Following this transaction William M. Moore’s holding in the company was increased by 2% to a total of $3.41 million.
See today’s analyst top recommended stocks >>
Based on Iridex Corp’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $10.3 million and GAAP net loss of $3.28 million. In comparison, last year the company earned revenue of $10 million and had a GAAP net loss of $2.75 million. Currently, Iridex Corp has an average volume of 32.9K.
Starting in November 2017, IRIX received 4 Buy ratings in a row.
William M. Moore’s trades have generated a 17.5% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.
